• Dovitinib (TKI-258): Applied Workflows for RTK-Driven Cancer

  2026-07-24

  Dovitinib (TKI-258) empowers researchers to dissect complex RTK signaling and induce apoptosis in diverse cancer models. This guide provides workflow enhancements, protocol parameters, and troubleshooting strategies for maximizing data reliability and translational value in oncology research using APExBIO’s Dovitinib.

• DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution

  2026-07-24

  DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution enables rapid and reliable nuclear visualization, cell viability assessment, and apoptosis detection in fixed or membrane-compromised cells. It is not suitable for live-cell imaging due to weak cell permeability. Ideal use cases include fluorescence microscopy and flow cytometry workflows where clear and consistent nuclear staining is required.

• Exemestane: Steroidal Aromatase Inhibitor for Precision Brea

  2026-07-23

  Exemestane stands out as a selective, irreversible steroidal aromatase inhibitor critical for translational breast cancer research. This guide details optimized protocols, advanced use-cases, and troubleshooting strategies to maximize experimental reliability and data quality.

• Z-VAD-FMK in Apoptosis Assays: Protocols, Applications, and

  2026-07-23

  Z-VAD-FMK delivers precise, irreversible inhibition of caspases for robust apoptosis pathway dissection in both cancer and immune cell models. This article details experimental workflows, troubleshooting tactics, and workflow enhancements—anchored in recent research and real-world protocol experience.

• Norovirus Hijacks NINJ1 for Selective NS1 Protein Secretion

  2026-07-22

  This study uncovers how murine norovirus (MNoV) co-opts the host protein NINJ1 to selectively secrete its viral protein NS1, using a non-canonical pathway dependent on caspase-3. These findings reveal new mechanistic insight into regulated plasma membrane rupture during infection and its implications for host-pathogen interactions.

• Nilotinib (AMN-107): Optimized Workflows for Kinase-Driven R

  2026-07-22

  Nilotinib (AMN-107) delivers robust, selective inhibition of BCR-ABL and key mutant kinases, making it indispensable in chronic myeloid leukemia and kinase pathway studies. This article translates recent translational research breakthroughs and hands-on protocol enhancements into actionable guidance for maximizing experimental success.

• ELP-Mediated p21 Delivery Suppresses Glioblastoma Cell Growt

  2026-07-21

  This study demonstrates that elastin-like polypeptide (ELP)-mediated delivery of a p21-derived cell cycle inhibitory peptide can efficiently suppress proliferation in diverse glioblastoma cell lines without primarily inducing apoptosis. The findings highlight the potential of ELP-based cytostatic platforms for overcoming barriers in peptide delivery and advancing glioblastoma therapeutics.

• FDA-Approved Drugs Suppress MERS-CoV Replication In Vitro

  2026-07-21

  de Wilde et al. conducted a systematic screen of an FDA-approved compound library and identified four small-molecule inhibitors that reduce MERS-CoV replication in cell culture. This work not only spotlights urgent antiviral candidates for emerging zoonotic coronaviruses but also sets a precedent for rapid drug repurposing strategies.

• Reversine (A3760): Reliable Aurora Kinase Inhibition in Canc

  2026-07-20

  This article provides a scenario-driven guide for biomedical researchers tackling cell proliferation and apoptosis assays using Reversine (SKU A3760), a validated Aurora kinase inhibitor. By addressing common experimental challenges and workflow questions, it demonstrates how Reversine delivers reproducible, data-backed results in cancer cell models and developmental biology. The content emphasizes evidence-based practices, referencing quantitative literature and the unique formulation advantages of Reversine from APExBIO.

• FLT3-TAZ Signaling Drives Drug Resistance in BP-CML: Insight

  2026-07-20

  Shin et al. provide compelling evidence that FLT3 signaling is a critical driver of blast phase chronic myeloid leukemia (BP-CML) drug resistance, independent of BCR::ABL1 mutations. Their work establishes FLT3 as both a prognostic marker and a therapeutic target, opening avenues for repurposing FLT3 inhibitors in combination regimens to overcome resistance in BP-CML.

• Imipenem in Antibacterial Research: Resistance Evolution and

  2026-07-19

  Explore how Imipenem, a semisynthetic thienamycin antibiotic, empowers next-generation antibacterial research amid rising resistance. This article uniquely bridges molecular mechanisms, real-world resistance data, and advanced assay design.

• HDAC6 Inhibition and Sphingolipid Metabolism: The Next Front

  2026-07-18

  This article explores how selective HDAC6 inhibition with Rocilinostat (ACY-1215) reshapes translational research in multiple myeloma and neurodevelopment, bridging epigenetic regulation and sphingolipid metabolism for innovative assay design and therapeutic strategy.

• L. gasseri ATCC33323 Modulates Colitis via NR1I3-Driven E-ca

  2026-07-17

  A recent study demonstrates that Lactobacillus gasseri ATCC33323 ameliorates DSS-induced colitis in mice by enhancing intestinal barrier integrity through NR1I3-mediated regulation of E-cadherin. This mechanistic insight advances our understanding of probiotic-based interventions for inflammatory bowel disease.

• Moxidectin Enhances Polyene Efficacy Against Oral Candidiasi

  2026-07-17

  The study uncovers that moxidectin elevates ergosterol biosynthesis in Candida albicans, amplifying the antifungal activity of polyenes such as nystatin and amphotericin B against oral candidiasis. This synergy offers a promising strategy to address antifungal resistance and reduce drug dosages, with clear implications for laboratory and preclinical research.

• EZ Cap™ Firefly Luciferase mRNA: Precision Reporter for Tran

  2026-07-16

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure delivers unmatched stability and translational efficiency for molecular biology assays. Its design enables robust gene regulation studies, in vivo imaging, and reliable mRNA delivery, minimizing immune activation and maximizing reproducibility.

16237 records 1/1083 page Next 12345 下5页 Last page